Elucidating Differences in Early-Stage Centrosome Amplification in Primary and Immortalized Mouse Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms25010383 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Masakazu Tanaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japa…. Hauptthemen laut MEDLINE: Nucleophosmin, Fibroblasts, Benzodiazepines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The centrosome is involved in cytoplasmic microtubule organization during interphase and in mitotic spindle assembly during cell division. Centrosome amplification (abnormal proliferation of centrosome number) has been observed in several types of cancer and in precancerous conditions. Therefore, it is important to elucidate the mechanism of centrosome amplification in order to understand the early stage of carcinogenesis. Primary cells could be used to better understand the early stage of carcinogenesis rather than immortalized cells, which tend to have various genetic and epigenetic changes. Previously, we demonstrated that a poly(ADP-ribose) polymerase (PARP) inhibitor, 3-aminobenzamide (3AB), which is known to be nontoxic and nonmutagenic, could induce centrosome amplification and chromosomal aneuploidy in CHO-K1 cells. In this study, we compared primary mouse embryonic fibroblasts (MEF) and immortalized MEF using 3AB. Although centrosome amplification was induced with 3AB treatment in immortalized MEF, a more potent PARP inhibitor, AG14361, was required for primary MEF. However, after centrosome amplification, neither 3AB in immortalized MEF nor AG14361 in primary MEF caused chromosomal aneuploidy, suggesting that further genetic and/or epigenetic change(s) are required to exhibit aneuploidy. The DNA-damaging agents doxorubicin and γ-irradiation can cause cancer and centrosome amplification in experimental animals. Although doxorubicin and γ-irradiation induced centrosome amplification and led to decreased p27Kip protein levels in immortalized MEF and primary MEF, the phosphorylation ratio of nucleophosmin (Thr199) increased in immortalized MEF, whereas it decreased in primary MEF. These results suggest that there exists a yet unidentified pathway, different from the nucleophosmin phosphorylation pathway, which can cause centrosome amplification in primary MEF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.
- Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, 1266 Tamura, Nagahama 526-0829, Japan.
ORCID-Profile: Masakazu Tanaka, Masanao Miwa
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tanaka, M., Yamada, M., Mushiake, M., Tsuda, M., & Miwa, M. (2023). Elucidating Differences in Early-Stage Centrosome Amplification in Primary and Immortalized Mouse Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010383
Vancouver
Tanaka M, Yamada M, Mushiake M, Tsuda M, Miwa M. Elucidating Differences in Early-Stage Centrosome Amplification in Primary and Immortalized Mouse Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010383
BibTeX
@article{Tanaka2023,
author = {Tanaka, Masakazu and Yamada, Masaki and Mushiake, Masatoshi and Tsuda, Masataka and Miwa, Masanao},
title = {Elucidating Differences in Early-Stage Centrosome Amplification in Primary and Immortalized Mouse Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010383}
}
EUVIMED